Robert E. Bancroft - 29 Apr 2025 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
President & CEO, Director
Signature
/s/ Alexander Wilson, as attorney-in-fact for Robert E. Bancroft
Issuer symbol
AEON
Transactions as of
29 Apr 2025
Net transactions value
$0
Form type
4
Filing time
01 May 2025, 16:50:50 UTC
Next filing
16 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +59,034 $0.000000 59,034 29 Apr 2025 Class A Common Stock 59,034 $0.4100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on each anniversary measured from April 29, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.